| Name | Title | Contact Details |
|---|
Albany Med is the region`s only academic health sciences center, serving more than three million people in the 25 counties of northeastern New York and western New England. It incorporates the 734-bed Albany Medical Center Hospital, which offers the widest range of medical and surgical services in the region, and the Albany Medical College, which trains the next generation of doctors, scientists and other healthcare professionals, and which also includes a biomedical research enterprise and the region`s largest physicians practice with 425 doctors. Albany Med works with dozens of community partners to improve the region`s health and quality of life. Programs include: regional Trauma Center; regional AIDS Treatment Center; Regional Resource Center; region`s most sophisticated Emergency Department; air medical transport service (LifeNet); region`s only kidney and pancreas transplant program; Children`s Hospital, including peds and neonatal ICUs and the Center for Childhood Cancer and Blood Disorders.
Sparta Community Hospital is a Sparta, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Joseph's Healthcare System physicians, nurses and health care providers saw over 1.6 million patients last year and have been a part of many exciting health care advances including: Clinical collaboration with St. Jude Children's Research Hospital launched using new high definition Telemedicine Suite at St. Joseph's Children's Hospital Alfiero and Lucia Palestroni Birth Defects Center at St. Joseph's Children's Hospital dedicated Expanded Emergency Department and MRI Suite dedicated Outpatient Cardiac Catheterization Unit in Wayne First Cervical Disc Replacement in New Jersey
Hammond Henry Hospital is a Geneseo, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.